prostaid

Live EstablishedMicroLow

prostaid Company Information

Share PROSTAID

Company Number

05953090

Directors

Stuart Berry

Robert Banner

View All

Shareholders

-

Group Structure

View All

Industry

Hospital activities

 +3

Registered Address

17 torrington close, wigston, leicester, leicestershire, LE18 2RY

prostaid Estimated Valuation

£112.8k

Pomanda estimates the enterprise value of PROSTAID at £112.8k based on a Turnover of £177.5k and 0.64x industry multiple (adjusted for size and gross margin).

prostaid Estimated Valuation

£0

Pomanda estimates the enterprise value of PROSTAID at £0 based on an EBITDA of £-22.6k and a 4.55x industry multiple (adjusted for size and gross margin).

prostaid Estimated Valuation

£822.5k

Pomanda estimates the enterprise value of PROSTAID at £822.5k based on Net Assets of £311.1k and 2.64x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Prostaid Overview

Prostaid is a live company located in leicester, LE18 2RY with a Companies House number of 05953090. It operates in the other education n.e.c. sector, SIC Code 85590. Founded in October 2006, it's largest shareholder is unknown. Prostaid is a established, micro sized company, Pomanda has estimated its turnover at £177.5k with low growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Prostaid Health Check

Pomanda's financial health check has awarded Prostaid a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

4 Weak

size

Size

annual sales of £177.5k, make it smaller than the average company (£1.2m)

£177.5k - Prostaid

£1.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 1%, show it is growing at a slower rate (6.4%)

1% - Prostaid

6.4% - Industry AVG

production

Production

with a gross margin of 52.7%, this company has a comparable cost of product (52.7%)

52.7% - Prostaid

52.7% - Industry AVG

profitability

Profitability

an operating margin of -12.9% make it less profitable than the average company (5.9%)

-12.9% - Prostaid

5.9% - Industry AVG

employees

Employees

with 1 employees, this is below the industry average (20)

1 - Prostaid

20 - Industry AVG

paystructure

Pay Structure

on an average salary of £28.1k, the company has an equivalent pay structure (£28.1k)

£28.1k - Prostaid

£28.1k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £177.5k, this is more efficient (£53.7k)

£177.5k - Prostaid

£53.7k - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Prostaid

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Prostaid

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Prostaid

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 4732 weeks, this is more cash available to meet short term requirements (124 weeks)

4732 weeks - Prostaid

124 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 1%, this is a lower level of debt than the average (28.4%)

1% - Prostaid

28.4% - Industry AVG

PROSTAID financials

EXPORTms excel logo

Prostaid's latest turnover from October 2023 is £177.5 thousand and the company has net assets of £311.1 thousand. According to their latest financial statements, Prostaid has 1 employee and maintains cash reserves of £296.4 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Turnover177,483183,168121,781171,655125,112118,175189,146237,859220,188190,591142,149161,950168,160152,616120,770
Other Income Or Grants
Cost Of Sales84,01586,81956,95184,09558,69656,28384,754128,652126,798111,54283,60393,72596,03486,62696,616
Gross Profit93,46896,34964,83087,56066,41661,892104,392109,20793,39079,04958,54668,22572,12665,99024,154
Admin Expenses116,29276,39667,69438,65885,11284,20996,183137,90080,65429,72764,29769,53435,770-5,7334,877
Operating Profit-22,82419,953-2,86448,902-18,696-22,3178,209-28,69312,73649,322-5,751-1,30936,35671,72319,277
Interest Payable
Interest Receivable
Pre-Tax Profit-6,49921,815-2,64839,841-16,647-20,1187,232-27,96111,35439,989-4,520-4427,76552,32214,190
Tax
Profit After Tax-6,49921,815-2,64839,841-16,647-20,1187,232-27,96111,35439,989-4,520-4427,76552,32214,190
Dividends Paid
Retained Profit-6,49921,815-2,64839,841-16,647-20,1187,232-27,96111,35439,989-4,520-4427,76552,32214,190
Employee Costs28,07126,11225,23524,67124,25224,042117,58216,19015,13915,47213,01212,77112,19011,86412,724
Number Of Employees11111156654444
EBITDA*-22,63220,558-1,89349,725-17,194-21,3769,152-20,39721,86758,1019696,46643,54076,04323,329

* Earnings Before Interest, Tax, Depreciation and Amortisation

Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Tangible Assets3265187991,3482,1719611,53516,36813,91221,97710,94117,66125,4368,41011,773
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets3265187991,3482,1719611,53516,36813,91221,97710,94117,66125,4368,41011,773
Stock & work in progress25763507
Trade Debtors2362876,4253,9001,0002,9909,46417,83320,39018,8446,54929,4597,037
Group Debtors
Misc Debtors17,616553,7305005001,2439,9301,7781,660500780278
Cash296,437325,484305,925309,817259,418286,943299,353276,365309,638272,837245,920246,341259,793205,964172,497
misc current assets5
total current assets314,053325,539309,896310,604266,343292,086310,283281,133320,762291,427267,153265,970266,342235,423179,534
total assets314,379326,057310,695311,952268,514293,047311,818297,501334,674313,404278,094283,631291,778243,833191,307
Bank overdraft3,000
Bank loan
Trade Creditors 1820
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities3,2578,43611,88913,4989,90016,96716,4409,35518,5678,65113,33014,34722,4502,2702,066
total current liabilities3,2578,43614,88913,4989,90117,78716,4409,35518,5678,65113,33014,34722,4502,2702,066
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities3,2578,43614,88913,4989,90117,78716,4409,35518,5678,65113,33014,34722,4502,2702,066
net assets311,122317,621295,806298,454258,613275,260295,378288,146316,107304,753264,764269,284269,328241,563189,241
total shareholders funds311,122317,621295,806298,454258,613275,260295,378288,146316,107304,753264,764269,284269,328241,563189,241
Oct 2023Oct 2022Oct 2021Oct 2020Oct 2019Oct 2018Oct 2017Oct 2016Oct 2015Oct 2014Oct 2013Oct 2012Oct 2011Oct 2010Oct 2009
Operating Activities
Operating Profit-22,82419,953-2,86448,902-18,696-22,3178,209-28,69312,73649,322-5,751-1,30936,35671,72319,277
Depreciation1926059718231,5029419438,2969,1318,7796,7207,7757,1844,3204,052
Amortisation
Tax
Stock-257194-444507
Debtors17,561-3,9113,179-6,1381,782-5,7876,162-6,356-7,209-2,8372,04812,573-22,91022,4227,037
Creditors-1-819820
Accruals and Deferred Income-5,179-3,453-1,6093,598-7,0675277,085-9,2129,916-4,679-1,017-8,10320,1802042,066
Deferred Taxes & Provisions
Cash flow from operations-45,37221,016-6,68159,460-26,862-14,24210,075-23,25339,24956,065-1,652-14,71786,63053,82518,358
Investing Activities
capital expenditure-324-422-2,712-36713,890-10,752-1,066-19,815-24,210-957-15,825
Change in Investments
cash flow from investments-324-422-2,712-36713,890-10,752-1,066-19,815-24,210-957-15,825
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue175,051
interest
cash flow from financing175,051
cash and cash equivalents
cash-29,04719,559-3,89250,399-27,525-12,41022,988-33,27336,80126,917-421-13,45253,82933,467172,497
overdraft-3,0003,000
change in cash-29,04722,559-6,89250,399-27,525-12,41022,988-33,27336,80126,917-421-13,45253,82933,467172,497

prostaid Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for prostaid. Get real-time insights into prostaid's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Prostaid Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for prostaid by selecting its closest rivals, whether from the EDUCATION sector, other micro companies, companies in LE18 area or any other competitors across 12 key performance metrics.

prostaid Ownership

PROSTAID group structure

Prostaid has no subsidiary companies.

Ultimate parent company

PROSTAID

05953090

PROSTAID Shareholders

--

prostaid directors

Prostaid currently has 12 directors. The longest serving directors include Mr Stuart Berry (Oct 2006) and Mr Robert Banner (Oct 2006).

officercountryagestartendrole
Mr Stuart Berry81 years Oct 2006- Director
Mr Robert BannerEngland79 years Oct 2006- Director
Mr John BirdUnited Kingdom74 years Oct 2008- Director
Mr Mark Dunkley64 years Aug 2009- Director
Mr Scott McLarenEngland46 years Apr 2015- Director
Mr Graydon Thwaite67 years Dec 2015- Director
Mrs Joanne Wortley53 years Oct 2018- Director
Mr Christopher Kent42 years Oct 2018- Director
Mr David MerrimanEngland68 years Jul 2021- Director
Mr Peter Ross36 years Mar 2023- Director

P&L

October 2023

turnover

177.5k

-3%

operating profit

-22.8k

0%

gross margin

52.7%

+0.12%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

October 2023

net assets

311.1k

-0.02%

total assets

314.4k

-0.04%

cash

296.4k

-0.09%

net assets

Total assets minus all liabilities

prostaid company details

company number

05953090

Type

Private Limited by guarantee without Share Capital Exempt from using Limited

industry

86101 - Hospital activities

86900 - Other human health activities

85590 - Other education n.e.c.

incorporation date

October 2006

age

19

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

October 2023

previous names

N/A

accountant

RICHARD BUCKBY

auditor

-

address

17 torrington close, wigston, leicester, leicestershire, LE18 2RY

Bank

HSBC BANK PLC, HSBC BANK PLC, HSBC BANK PLC

Legal Advisor

-

prostaid Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to prostaid.

prostaid Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PROSTAID. This can take several minutes, an email will notify you when this has completed.

prostaid Companies House Filings - See Documents

datedescriptionview/download